“In the study, barely a quarter of the substandard products were identified through visual inspection. Laboratory testing identified the rest.”

About one in six cancer drugs tested in Ethiopia, Kenya, Malawi and Cameroon had the wrong amount of active ingredient. Some came from major hospitals. Three quarters looked fine and only failed in the lab. Patients pay for chemo that lets the tumor keep growing.